Clearview ULTRA FOB is a rapid, two-step immunochemical test for the detection of fecal occult blood.

Clearly Different

Clearview's patented innovative technology provides highly accurate detection of fecal occult blood.

• Fast: two easy steps with a positive result in as little as 1 minute
• Easy: CLIA-waived, easy-to-use test requires no training
• Reliable: built-in control ensures accuracy
• Flexible: requires only one sample and no dietary restrictions

Clearly Better

Clearview ULTRA FOB offers important benefits for you and your patients.

• Aids in the diagnosis of gastrointestinal disorders, which may lead to colorectal cancer if not treated
• Early diagnosis and treatment can lead to a significant reduction in mortality from colorectal cancer
• Convenience and ease of collection may greatly improve patient compliance
• As an immunochemical test, offers significantly higher reimbursement than traditional guaiac-based tests

Clearview ULTRA FOB Procedure

Shake sample collection bottle vigorously, then remove the white cap on the vial. Place the sample end of the dipstick into the sample collection bottle.

Read results in 5 minutes. Specimens with high concentrations of Hb may produce positive results in as little as 1 minute. For full instructions for use, see package insert.

About Colorectal Cancer

Colorectal cancer (CRC) is the third most common cancer both in men and women.¹ In fact, over 56,000 Americans die from CRC every year.¹ More than 90% of cases of CRC occur in people over the age of 50.¹ However, when CRC is detected early, it is 90% curable with treatment.¹

Because CRC usually causes no symptoms in these early stages, screening is often the only way to detect early-stage CRC.¹ The American Cancer Society recommends that men and women 50 years of age and older should be screened for CRC.²

Fecal occult blood (FOB) screening detects blood in the stool that is associated with gastrointestinal disorders such as diverticulitis, polyps, and Crohn's disease that may lead to CRC if not treated. Early diagnosis of CRC through FOB testing and subsequent treatment has been shown to significantly reduce mortality from CRC.

References

1. American Cancer Society. Colorectal Cancer Facts & Figures: Special Edition 2005. Available at: http://www.cancer.org. Accessed April 13, 2005.
2. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer, 2003. CA Cancer J Clin. 2003;53:27-43.